SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-065142
Filing Date
2018-12-18
Accepted
2018-12-18 16:31:49
Documents
93
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv508180-10k.htm 10-K 2028528
2 EXHIBIT 10.12 tv508180_ex10-12.htm EX-10.12 58506
3 EXHIBIT 10.18 tv508180_ex10-18.htm EX-10.18 267105
4 EXHIBIT 10.26 tv508180_ex10-26.htm EX-10.26 28128
5 EXHIBIT 23.1 tv508180_ex23-1.htm EX-23.1 3129
6 EXHIBIT 31.1 tv508180_ex31-1.htm EX-31.1 9229
7 EXHIBIT 32.1 tv508180_ex32-1.htm EX-32.1 6032
14 GRAPHIC tv508180-chart01.jpg GRAPHIC 107251
  Complete submission text file 0001144204-18-065142.txt   8549931

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ons-20180930.xml EX-101.INS 1371976
9 XBRL SCHEMA FILE ons-20180930.xsd EX-101.SCH 76234
10 XBRL CALCULATION FILE ons-20180930_cal.xml EX-101.CAL 54678
11 XBRL DEFINITION FILE ons-20180930_def.xml EX-101.DEF 321063
12 XBRL LABEL FILE ons-20180930_lab.xml EX-101.LAB 685225
13 XBRL PRESENTATION FILE ons-20180930_pre.xml EX-101.PRE 503427
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37759 | Film No.: 181240904
SIC: 2836 Biological Products, (No Diagnostic Substances)